The AIM with Immunotherapy Initiative – Home › Forums › Immunotherapy › Side-effect management › Standard Doses – pembrolizumab › Reply To: Standard Doses – pembrolizumab
October 3, 2017 at 7:03 pm
#4192
There are no standard dosage reductions for irAEs associated with pembrolizumab. The dose is either held until the irAE resolves sufficiently (typically to Grade 0 or Grade 1) or, if the irAE is severe enough, pembrolizumab is discontinued permanently.